Cited by 324Pancreatic function and diabetesDiabetes Treatment and ManagementMetabolism, Diabetes, and Cancer

Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells

Open access
Parker, H. E., Habib, A. M., Rogers, G. J., Gribble, F. M., Reimann, F.·2009·Diabetologia

Abstract

AIMS/HYPOTHESIS: Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone with anti-apoptotic effects on the pancreatic beta cell. The aim of this study was to generate transgenic mice with fluorescently labelled GIP-secreting K cells and to use these to investigate pathways by which K cells detect nutrients. METHODS: Transgenic mice were generated in which the GIP promoter drives the expression of the yellow fluorescent protein Venus. Fluorescent cells were purified by flow cytometry and analysed by quantitative RT-PCR. GIP secretion was assayed in primary cultures of small intestine. RESULTS: Expression of Venus in transgenic mice was restricted to K cells, as assessed by immunofluorescence and measurements of the Gip mRNA and GIP protein contents of purified cells. K cells expressed high levels of mRNA for Kir6.2 (also known as Kcnj11), Sur1 (also known as Abcc8), Sglt1 (also known as Slc5a1), and of the G-protein-coupled lipid receptors Gpr40 (also known as Ffar1), Gpr119 and Gpr120. In primary cultures, GIP release was stimulated by glucose, glutamine and linoleic acid, and potentiated by forskolin plus 3-isobutyl-1-methylxanthine (IBMX), but was unaffected by the artificial sweetener sucralose. Secretion was half-maximal at 0.6 mmol/l glucose and partially mimicked by alpha-methylglucopyranoside, suggesting the involvement of SGLT1. Tolbutamide triggered secretion under basal conditions, whereas diazoxide suppressed responses in forskolin/IBMX. CONCLUSIONS/INTERPRETATION: These transgenic mice and primary culture techniques provide novel opportunities to interrogate the mechanisms of GIP secretion. Glucose-triggered GIP secretion was SGLT1-dependent and modulated by K(ATP) channel activity but not determined by sweet taste receptors. Synergistic stimulation by elevated cAMP and glucose suggests that targeting appropriate G-protein-coupled receptors may provide opportunities to modulate GIP release in vivo.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-008-1202-x

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • GLP-1 and GIP are secreted from enteroendocrine L-cells and K-cells upon glucose, fructose, amino acid and free fatty acid ingestion and potentiate insulin release through the incretin effect.

    “The gut-derived hormones GLP-1 and GIP, which are secreted from enteroendocrine L-cells66 and K-cells,67 respectively, upon glucose,66, 68 fructose,69 amino acid70 and free fatty acid (FFA)71, 72 ingestion, also potentiate insulin release through the so-called incretin effect.”

    From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [67]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Parker, H. E., Habib, A. M., Rogers, G. J., Gribble, F. M., & Reimann, F.
Affiliations
Addenbrooke's Hospital (GB)
Corresponding author
  • Gribble, F. M.
  • Reimann, F.
Venue
Diabetologia
Published
2008-12-11
Volume
52
Issue
2
Pages
289-298
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2045343006
Cited by
324
References
47
Citations by year
2026: 10 · 2025: 11 · 2024: 10 · 2023: 10 · 2022: 7 · 2021: 12 · 2020: 9 · 2019: 15 · 2018: 21 · 2017: 17 · 2016: 31 · 2015: 24 · 2014: 28 · 2013: 21 · 2012: 33
FWCI
22.89
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Diabetologia (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • GlaxoSmithKline
  • Wellcome Trust (071187, 084210)
  • Lister Institute of Preventive Medicine
  • Medical Research Council
  • Cambridge Institute for Medical Research, University of Cambridge
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
glucose-dependent insulinotropic polypeptide, GIP secretion, K cells, nutrient sensing, SGLT1, GPR40, GPR119, GPR120, incretins, transgenic mice, cAMP signaling, tolbutamide, diazoxide, small intestine
MeSH terms
Actins, Cyclic AMP, Animals, Calcium-Binding Proteins, Flow Cytometry, Gastric Inhibitory Polypeptide, Glucose, Killer Cells, Natural, Lipoproteins, Mice, Transgenic, Promoter Regions, Genetic, Receptors, Gastrointestinal Hormone, Tetradecanoylphorbol Acetate, Chromosomes, Artificial, Bacterial, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review